VR Adviser, LLC Diversified Active

CIK: 0001615982 · Show all filings

Period: Q4 2023 (← Previous) (Next →)

Filing Date: Feb 14, 2024

Total Value ($000): $1,458,068 (100.0% shares, 0.0% debt)

Holdings (36)

— RAYZEBIO INC 17.2%

Value ($000) $250,574 Shares 4,030,471 Est. Cost $22.20 Unrealized —

APGE APOGEE THERAPEUTICS INC 16.3%

Value ($000) $237,303 Shares 8,493,321 Est. Cost $22.03 Unrealized -9.0%

PHVS PHARVARIS N V 6.5%

Value ($000) $95,247 Shares 3,395,606 Est. Cost $15.96 Unrealized +26.7%

VRDN VIRIDIAN THERAPEUTICS INC 5.8%

Value ($000) $84,564 Shares 3,882,623 Est. Cost $19.32 Unrealized -18.3%

FDMT 4D MOLECULAR THERAPEUTICS IN 4.8%

Value ($000) $69,371 Shares 3,424,031 Est. Cost $17.76 Unrealized -25.9%

— MERUS N V 4.1%

Value ($000) $59,076 Shares 2,148,214 Est. Cost $20.36 Unrealized —

CABA CABALETTA BIO INC 4.0%

Value ($000) $58,202 Shares 2,563,952 Est. Cost $6.85 Unrealized +145.5%

SYRE SPYRE THERAPEUTICS INC 3.5%

Value ($000) $51,061 Shares 2,372,714 Est. Cost $13.78 Unrealized 0.0%

KALV KALVISTA PHARMACEUTICALS INC 3.4%

Value ($000) $50,136 Shares 4,092,731 Est. Cost $6.43 Unrealized +41.5%

ELVN ENLIVEN THERAPEUTICS INC 2.8%

Value ($000) $40,896 Shares 2,954,902 Est. Cost $19.48 Unrealized -37.2%

OCUL OCULAR THERAPEUTIX INC 2.4%

Value ($000) $34,680 Shares 7,775,760 Est. Cost $2.96 Unrealized 0.0%

— HILLEVAX INC 2.3%

Value ($000) $33,304 Shares 2,075,000 Est. Cost $13.50 Unrealized —

— AMBRX BIOPHARMA INC 2.0%

Value ($000) $29,477 Shares 2,070,000 Est. Cost $14.24 Unrealized —

TERN TERNS PHARMACEUTICALS INC 2.0%

Value ($000) $29,186 Shares 4,497,117 Est. Cost $4.28 Unrealized +23.6%

DYN DYNE THERAPEUTICS INC 2.0%

Value ($000) $28,913 Shares 2,173,913 Est. Cost $11.80 Unrealized -17.2%

COGT COGENT BIOSCIENCES INC 1.9%

Value ($000) $27,543 Shares 4,684,167 Est. Cost $8.79 Unrealized -12.8%

CELC CELCUITY INC 1.9%

Value ($000) $27,472 Shares 1,885,538 Est. Cost $10.24 Unrealized +18.0%

— MERSANA THERAPEUTICS INC 1.8%

Value ($000) $26,281 Shares 11,328,000 Est. Cost $1.27 Unrealized —

ARVN ARVINAS INC 1.8%

Value ($000) $25,840 Shares 627,788 Est. Cost $23.38 Unrealized 0.0%

— ASTRIA THERAPEUTICS INC 1.7%

Value ($000) $24,774 Shares 3,225,806 Est. Cost $7.68 Unrealized —

RYTM RHYTHM PHARMACEUTICALS INC 1.6%

Value ($000) $22,800 Shares 495,983 Est. Cost $18.05 Unrealized +74.8%

ORIC ORIC PHARMACEUTICALS INC 1.5%

Value ($000) $22,341 Shares 2,428,385 Est. Cost $5.86 Unrealized +23.3%

— APPLIED THERAPEUTICS INC 1.4%

Value ($000) $20,938 Shares 6,250,000 Est. Cost $1.48 Unrealized —

TSHA TAYSHA GENE THERAPIES INC 1.3%

Value ($000) $18,431 Shares 10,412,872 Est. Cost $1.87 Unrealized +6.7%

SVRA SAVARA INC 1.1%

Value ($000) $16,450 Shares 3,500,000 Est. Cost $1.58 Unrealized +142.8%

— LYRA THERAPEUTICS INC 0.9%

Value ($000) $13,496 Shares 2,575,593 Est. Cost $5.39 Unrealized —

ABVX ABIVAX SA 0.7%

Value ($000) $10,685 Shares 998,570 Est. Cost $10.70 Unrealized —

DNTH DIANTHUS THERAPEUTICS INC 0.7%

Value ($000) $9,648 Shares 927,706 Est. Cost $12.62 Unrealized -12.4%

PRAX PRAXIS PRECISION MEDICINES I 0.5%

Value ($000) $7,879 Shares 353,626 Est. Cost $18.01 Unrealized 0.0%

GHRS GH RESEARCH PLC 0.5%

Value ($000) $7,646 Shares 1,318,327 Est. Cost $17.34 Unrealized -59.3%

— ACELYRIN INC 0.5%

Value ($000) $6,991 Shares 937,113 Est. Cost $9.96 Unrealized —

EYPT EYEPOINT PHARMACEUTICALS INC 0.4%

Value ($000) $5,778 Shares 250,000 Est. Cost $11.18 Unrealized 0.0%

TRVI TREVI THERAPEUTICS INC 0.3%

Value ($000) $4,586 Shares 3,422,397 Est. Cost $2.46 Unrealized -38.5%

— ADVERUM BIOTECHNOLOGIES INC 0.3%

Value ($000) $3,875 Shares 5,147,547 Est. Cost $1.55 Unrealized —

MIST MILESTONE PHARMACEUTICALS IN 0.1%

Value ($000) $1,545 Shares 925,048 Est. Cost $7.58 Unrealized -64.2%

OLMA OLEMA PHARMACEUTICALS INC 0.1%

Value ($000) $1,081 Shares 77,042 Est. Cost $10.19 Unrealized +31.8%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	RAYZEBIO INC	4,030,471	$250,574	17.2%	$22.20	—	COM	75525N107
APGE	APOGEE THERAPEUTICS INC	8,493,321	$237,303	16.3%	$22.03	-9.0%	COM	03770N101
PHVS	PHARVARIS N V	3,395,606	$95,247	6.5%	$15.96	+26.7%	COM	N69605108
VRDN	VIRIDIAN THERAPEUTICS INC	3,882,623	$84,564	5.8%	$19.32	-18.3%	COM	92790C104
FDMT	4D MOLECULAR THERAPEUTICS IN	3,424,031	$69,371	4.8%	$17.76	-25.9%	COM	35104E100
—	MERUS N V	2,148,214	$59,076	4.1%	$20.36	—	COM	N5749R100
CABA	CABALETTA BIO INC	2,563,952	$58,202	4.0%	$6.85	+145.5%	COM	12674W109
SYRE	SPYRE THERAPEUTICS INC	2,372,714	$51,061	3.5%	$13.78	0.0%	COM NEW	00773J202
KALV	KALVISTA PHARMACEUTICALS INC	4,092,731	$50,136	3.4%	$6.43	+41.5%	COM	483497103
ELVN	ENLIVEN THERAPEUTICS INC	2,954,902	$40,896	2.8%	$19.48	-37.2%	COM	29337E102
OCUL	OCULAR THERAPEUTIX INC	7,775,760	$34,680	2.4%	$2.96	0.0%	COM	67576A100
—	HILLEVAX INC	2,075,000	$33,304	2.3%	$13.50	—	COM	43157M102
—	AMBRX BIOPHARMA INC	2,070,000	$29,477	2.0%	$14.24	—	COM	641871108
TERN	TERNS PHARMACEUTICALS INC	4,497,117	$29,186	2.0%	$4.28	+23.6%	COM	880881107
DYN	DYNE THERAPEUTICS INC	2,173,913	$28,913	2.0%	$11.80	-17.2%	COM	26818M108
COGT	COGENT BIOSCIENCES INC	4,684,167	$27,543	1.9%	$8.79	-12.8%	COM	19240Q201
CELC	CELCUITY INC	1,885,538	$27,472	1.9%	$10.24	+18.0%	COM	15102K100
—	MERSANA THERAPEUTICS INC	11,328,000	$26,281	1.8%	$1.27	—	COM	59045L106
ARVN	ARVINAS INC	627,788	$25,840	1.8%	$23.38	0.0%	COM	04335A105
—	ASTRIA THERAPEUTICS INC	3,225,806	$24,774	1.7%	$7.68	—	COM	04635X102
RYTM	RHYTHM PHARMACEUTICALS INC	495,983	$22,800	1.6%	$18.05	+74.8%	COM	76243J105
ORIC	ORIC PHARMACEUTICALS INC	2,428,385	$22,341	1.5%	$5.86	+23.3%	COM	68622P109
—	APPLIED THERAPEUTICS INC	6,250,000	$20,938	1.4%	$1.48	—	COM	03828A101
TSHA	TAYSHA GENE THERAPIES INC	10,412,872	$18,431	1.3%	$1.87	+6.7%	COM SHS	877619106
SVRA	SAVARA INC	3,500,000	$16,450	1.1%	$1.58	+142.8%	COM	805111101
—	LYRA THERAPEUTICS INC	2,575,593	$13,496	0.9%	$5.39	—	COM	55234L105
ABVX	ABIVAX SA	998,570	$10,685	0.7%	$10.70	—	SPONSORED ADS	00370M103
DNTH	DIANTHUS THERAPEUTICS INC	927,706	$9,648	0.7%	$12.62	-12.4%	COM	252828108
PRAX	PRAXIS PRECISION MEDICINES I	353,626	$7,879	0.5%	$18.01	0.0%	COM NEW	74006W207
GHRS	GH RESEARCH PLC	1,318,327	$7,646	0.5%	$17.34	-59.3%	ORDINARY SHARES	G3855L106
—	ACELYRIN INC	937,113	$6,991	0.5%	$9.96	—	COM	00445A100
EYPT	EYEPOINT PHARMACEUTICALS INC	250,000	$5,778	0.4%	$11.18	0.0%	COM NEW	30233G209
TRVI	TREVI THERAPEUTICS INC	3,422,397	$4,586	0.3%	$2.46	-38.5%	COM	89532M101
—	ADVERUM BIOTECHNOLOGIES INC	5,147,547	$3,875	0.3%	$1.55	—	COM	00773U108
MIST	MILESTONE PHARMACEUTICALS IN	925,048	$1,545	0.1%	$7.58	-64.2%	COM	59935V107
OLMA	OLEMA PHARMACEUTICALS INC	77,042	$1,081	0.1%	$10.19	+31.8%	COM	68062P106